Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020

Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020

Code: ARMMR163N | Published: May-2016 | Pages: 596 | Axis Research Mind
Price :
$4,800.00
USD

* Required Fields

$4,800.00

Details

Global Market Watch:
Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported by application; Stem Cells, Blood and Blood Products, Research and Pharmaceuticals…etc. Among the Human Biobanking Application market, Advance Application is the fastest growing market with a CAGR of 9.65%. Organs and Research application in human banking together accounts approximately for 24% of the market share. Stem Cells, Blood and Blood Products, Research market with a positive growth rate during the period. Human Biobanking Industry is playing an increasing role in development of therapies and diagnosis of diseases with well-maintained researchers and institutions.

Report Focus:
The report “Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

• Emerging market trends
• Advancements in the technological space
• Market demand of the segments (by-region)
• Key growth areas and market size
• Key competitor’s Edge

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with human biobanking applications market. Further, the subdivided categories include:
1. Stem Cells
2. Blood1 & Blood Products
3. Organs2
4. Advanced Applications
a. Biomarkers
b. Genomics3
c. Drug Discovery
d. Forensics
5. Research
6. Pharmaceuticals
7. Other4

1. Red Blood Cells, Plasma and Platelets
2. Tissue Sections, Liver, Eyes, Kidney, Brain, Heart and Other
3. DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.
4. Body Fluids (Synovial, Urine, Sputum, Buccal Scrapings and Sperm), Contract Services and Process Chemicals

The period considered for the human biobanking applications market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia- Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 157 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Table of Contents


I. REPORT FOCUS

A. INTRODUCTION
BIOREPOSITORY
CLASSIFYING BIOBANKS
STORING SAMPLES IN A BIOBANK
BIOSPECIMEN SECURITY AND STORAGE

THE GENERATIONAL EVOLUTION OF BIOBANK

PUTTING TOGETHER A BIO BANK WITH ITS REQUIREMENTS AND CAPACITIES
TECHNICAL REQUIREMENTS
FUNCTIONAL REQUIREMENTS

BIOREPOSITORY OPERATIONS
GETTING A BIOREPOSITORY ACCREDITED
THE ROLE OF SYNTHETIC DATA IN BIOBANK ANALYSIS

B. BIOBANKING BENEFITS
CONCLUSION

C. BIOSPECIMENS (COLLECTION, PROCESSING, STORAGE, RETRIEVAL AND DISSEMINATE)
BIOSPECIMENS IN CANCER RESEARCH

BIOSPECIMENS - THE LEGACY PLAN
DECADES OLD SPECIMENS MAY BE TODAY’S RESEARCH TREASURES

BIOSPECIMEN MANAGEMENT SYSTEM
THE MODERN APPROACH TO BIOBANKING
ISOLATING STOMACH-CELL POPULATIONS USING LCM
RESULTS FROM THE BPV PROGRAM
EVALUATION OF PRE-ANALYTICAL FACTORS ON IDENTIFICATION
OF COPY NUMBER VARIATIONS
THE IMPACT OF EX-VIVO ISCHEMIA TIME ON QUALITY OF RNA
THE IDEAL PHYSICAL ENVIRONMENT FOR BIOSPECIMENS
CASE STUDY: ADVANCED IT SYSTEM FOR RESEARCH BIOREPOSITORY
PHYSICAL PHENOMENON AT LOW TEMPERATURES
BIOLOGICAL PHENOMENON AT LOW TEMPERATURES
STORAGE METHODS FOR VARIOUS BIOSPECIMENS
1. STORING PROTEINS AND PURIFIED NUCLEIC ACIDS
2. STORING CRYO-PRESERVED CELLS
3. STORING TISSUES
CONCLUSION

TRANSPORTING BIOSPECIMENS

EFFECTS OF TRANSPORTATION ON MONONUCLEAR CELLS
FINDING BIO-SAMPLES
OUT OF THE COLD-DRY STATE
BANKING ON SUCCESS FOR PRECISION MEDICINE
THE CLOSE OF THE ULTIMATE PERIOD IN BIO-BANKING
COST OF VALUE STUDY: RELATE THE THEORY TO BIOBANKS

MALFUNCTION COSTS:

EXTERNAL STOPPAGE COSTS:
BIOBANK ECONOMIC MODELING TOOL: A COST IMPROVEMENT DEVICE FOR CONTINUITY OF BIO-BANKS
INSTITUTION OF AN ISO15189 ACCREDITED BIO-BANK FOR GLOBAL CLINICAL RESEARCH STUDIES
CRITICAL MOVES TO BUILD BIO-BANKS: STAGE WISE PROCESS FOR LOW INCOME NATIONS
THE INSTITUTION OF A BIO-BANK AND COHORT NETWORK (BCNET) FOR LOW AND MIDDLE INCOME COUNTRIES
BIO-BANKING AND TRANSLATIONAL MEDICINE: THE SCHOLARLY OUTLOOK
A WORKABLE METHODOLOGY DEVISED BY BIO-BANK GRAZ: A REPRESENTATION FOR OTHER UNIVERSITY-BASED INSTITUTIONS
THE SUSTAINABILITY ISSUE OF A COMMUNITY HOSPITAL-BASED BIO-BANK AND CORE MOLECULAR LABORATORY: THE BEAUMONT UNDERSTANDING
TO MAINTAIN A DISEASE CENTERED BIO-BANKING - AN ACTIVE APPROACH

D. BIOBANKING PRINCIPLES
NORMS BASED ON INTERFACE COMPREHENSION
DATA STANDARDS ARE NOT MAXIMIZED IN RESEARCH BIO-BANKING
DATA STANDARDS - PROPOSED BY OBBR AND ISBER
DATA STANDARDS PROGRAM FOR BIO-BANKS
DESIGN OF A REGISTRY OF STANDARD OPERATING PROTOCOLS FOR TISSUE COMPILATION

E. PATH BREAKING TECHNOLOGIES
THE BIO-BANK INFORMATION MANAGEMENT SYSTEM LIFE CYCLE ORGANIZATION AND THE BIMS CLOUD MANAGEMENT PLATFORM
AMALGAMATION OF STANDARD PRE-ANALYTICAL CODE WITH BIO-BANK ORGANIZATION SOFTWARE FREEZER PRO
EVALUATION OF COMPUTERIZATION TECHNOLOGIES AND PHYSICAL STORAGE AND RECOVERY
FUTURE OUTLOOK AND CONCERNS IN THE SETUP OF SOFTWARE SOLUTIONS IN AN INTERDISCIPLINARY CLINICAL BIOBANK
A MECHANICAL LABORATORY WORKFLOW FOR STOOL DNA REMOVAL
CONSISTENT WORKFLOW FOR BIO-MATERIAL APPEALS
PARTIALLY COMPUTERIZED BIO-BANK SAMPLE PROCESSING WITH A 384 HIGH DENSITY SAMPLE TUBE ROBOT DEPLOYED IN CANCER AND CARDIOVASCULAR RESEARCH
AN AUTONOMOUS APPRAISAL OF THE CRYOXTRACT CXT350 FROZEN BIO-SPECIMEN CORING APPLICATION WITH TISSUE AND STOOL FECAL SAMPLES
HEAT STANDARDIZATION OF TISSUE SAMPLES SUPPORTS MEASUREMENT WITHOUT INTRUSION FROM POST-MORTEM OCCURRENCES AND PERMITS FOR REFINEMENT BECAUSE OF MINIMIZED INTRA GROUP VARIABILITY
BIOT CRYOCARRIER - STANDARDIZED CRYOGENIC TEMPERATURE HANDLING OF BIOSPECIMENS
PROTECTION BY VAPORIZATION FOR BIO-BANKING
OPTIMUM SPECIMEN SECURITY WITH COMPLETE AUTOMATION CHARACTERISTICS: THE AUTOMATED LN2 VAPOUR PHASE FREEZER
EXERCISE OF ELECTRONIC P-CHIPS IN A MONO AND DUOTAGGING SYSTEM FOR SAMPLE TUBES USED IN BIO-BANKING
SAMPLE TRAIL AND PREREQUISITE WITH IPLEX® PRO SAMPLE ID
USAGE OF AN E-CONSENT SYSTEM FOR BIO-BANK PATIENT CONSENT – THE THREE WHYS
CELL LINE VERIFICATION WITH THE USE OF SNP TRACE™ PANEL: A HIGH-THROUGHPUT, AFFORDABLE SNPBASED INTERFACE FOR FINGERPRINTING, IDENTIFYING INFECTIVITY, AND ESTABLISH ORIGIN OF DERIVATIVE CELL LINES
NEXT-GENERATION DNA SEQUENCING WITH SUSTAINED PRESERVED SERUM SAMPLES
AN ASSESSMENT OF FROZEN ALIQUOTTING APPLICATION FOR THE STABILIZATION OF SMALL MOLECULE AND PEPTIDES IN BIO-ANALYTICAL TECHNOLOGY

F. BIOBANKING PERFORMANCES
PERFORMANCES INSIDE THE BIO-BANK
ETHICAL, LEGAL AND APPROPRIATE STRATEGIES
SOCIETAL COMMITMENT FOR GROWTH OF CDC POLICY LEADING SUPERVISION OF SPECIMENS ATTAINED FROM AMERICAN INDIAN/ALASKA NATIVE PEOPLE
LEGAL AND REGULATORY HURDLES THAT IMPACT COMPLETION OF AN INTER-INSTITUTIONAL BIO-BANK SYSTEM
IN –DEPTH APPRAISAL ON BIO-BANKING PERFORMANCES
SPECIMEN RESEARCH
SAFEGUARD AND CONTROL SAMPLE DATA
BIO-SAMPLES PRESERVATION AND SAFETY PRECAUTIONS
MONITOR SAMPLES THROUGH TRANSPORT
FARM OUT SAMPLES
CONCLUSION

G. BIOBANK APPLICATIONS

STEM CELLS
FUNDAMENTAL FEATURES IN SETTING UP A STEM CELL-SPECIFIC BANK
SAFEGUARDS TO FUTURE HEALTH VIA CORD BLOOD AND CORD TISSUE STEM CELLS
SAFEGUARD ONES HEALTH FOR YEARS TO COME

BLOOD AND ITS COMPONENTS
RED BLOOD CORPUSCLES
PLASMA
BLOOD PLATELETS
TYPES OF BIOBANKS

ORGAN AND TISSUE BIOBANK FOR THERAPY AND TRANSPLANTATION
GENETIC BIOBANKS
POPULATION BIOBANK
SOME COMMON OBJECTIVES OF BIOBANKS:
THERAPY FOR THE MOST PREVALENT GENETIC DISORDERS

PHARMACEUTICALS
CUSTOMIZED DRUGS
EXPANSION OF NOVEL DRUGS

RESEARCH
STEM CELLS
A BIOBANK’S IMPACT: ACHIEVING TRANSLATION MEDICINE IN CANCER RESEARCH
EFFECTS OF A BIOBANK ON CLINICAL RESEARCH
BIOBANK INVESTIGATIONS ADVANTAGES

H. BIOBANK - ADVANCED APPLICATIONS
CURRENT ROLE OF BIO-BANKING IN MEDICAL ENVIRONMENT
A CASE FOR OUTSOURCING
A BIOMATERIAL STORAGE PROVIDER
COLD-CHAIN MANAGEMENT, TRACKING AND MONITORING
BRAIN BANK

EXTRACTING A BRAIN

FIXATION ALTERNATIVES FOR RNA PRESERVATION
COMPARISON OF THE FLUIDIGM SNP TRACE™ PANEL AND DNAQUAL
THE CONNECTION BETWEEN CARDIAC TRANSPLANTATION AND BIOBANKS
GENTYPE-TISSUE EXPRESSION
FACTORS AFFECTING STORAGE OF BIOLOGICAL TISSUES
LONG-TERM STORAGE OF DNA: OLD AND NEW METHODS

CONCLUSION

I. CANCER BIOBANKING

THE ROLE OF BIOBANKS IN CANCER RESEARCH

BIOBANKS: THE BENCHMARKS
CASE STUDY: JANUS SERUM BANK
INFORMED CONSENT AMONGST DISADVANTAGED COMMUNITIES
FOR BIOBANK RESEARCH
ENHANCING COLLECTION METHODS AT THE UCCITB
THE ROLE OF THE CCGC IN CANCER RESEARCH IN CHINA
THE PCBN:

PROSTATE CANCER
OVERVIEW
PROSTATE CANCER BIOBANKING: COLLECTION METHODS AND EVALUATION TECHNIQUES
A PROSTATE CANCER BIOREPOSITORY TO SATISFY INTERNATIONAL COLLABORATIVE DEMANDS
PROCURE PROSTATE CANCER BIOBANK
MIRROR IMAGE METHOD: A NEW TECHNIQUE FOR HISTOLOGICAL ASSESSMENT OF TUMOR SAMPLES
NEW CONSENTING PROGRAMS IN THE WCB
NEXT-GENERATION CANCER BIOBANKING: SEQUENCING AND PERSONALIZED MEDICINE
WHAT ARE SUSTAINABILITY METRICS IN A CANCER-ORIENTED BIOBANK?
ESTIMATING BIOBANK INVENTORY REQUIREMENTS
PLATFORMS TO SCREEN NEW CANCER-INHIBITING DRUGS
THE DEVELOPMENT OF NEW TECHNIQUES TO PERFORM DOWNSTREAM ANALYSIS OF IMMUNO-STAINED FFPE SLIDES

A BIOBANK’S ECONOMIC DRIVERS
THE ROLE OF STANDARDIZED PROCEDURES IN BIOBANK MANAGEMENT DECREASING RESEARCH COSTS
ENHANCING PATIENT CARE AT LOWER COSTS

BIOBANKS AND CANCER EVOLUTION
BIOBANK TRENDS

BIOMARKERS
THE RELATION BETWEEN BIOMARKERS AND BIOBANKS
MAXIMIZING CHANCES OF BIOMARKER IDENTIFICATION
THE EFFECT OF PRE-ANALYTICAL VARIABLES ON TISSUES
EXAMPLES OF BIOMARKER IDENTIFICATION
IMMUNE CELLS AS BIOMARKERS FOR EXPOSURE TO IONIZING RADIATION:
FROZEN TISSUE-CORE ANALYSIS
STORAGE STABILITY OF CYTOKINE DIABETES BIOMARKERS

FORENSICS

DRUG BREAKTHROUGHS

J. HUMAN BIOBANKING APPLICATIONS - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

K. HUMAN BIOBANKING ADVANCED APPLICATIONS - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

II. MARKET ANALYSIS
HUMAN BIOBANKING APPLICATION - GLOBAL

HUMAN BIOBANKING APPLICATION – BY GEOGRAPHY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

HUMAN BIOBANKING - BY APPLICATIONS TYPE
HUMAN BIOBANKING APPLICATION - TYPE - BY GEOGRAPHY
STEM CELLS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

ADVANCED APPLICATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

ADVANCED APPLICATION - BY TYPE
ADVANCED APPLICATION – TYPE – BY GEOGRAPHY
BIOMARKERS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

DRUG DISCOVERY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

GENOMICS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

FORENSICS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

BLOOD AND BLOOD PRODUCTS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

ORGANS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

RESEARCH
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

PHARMACEUTICALS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

OTHER HUMAN BIOBANKING APPLICATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

B. GROWTH RATE ANALYSIS
GLOBAL HUMAN BIOBANKING APPLICATION - MARKET GROWTH RATES

HUMAN BIOBANKING APPLICATION MARKET - TYPE
GLOBAL HUMAN BIOBANKING APPLICATION – TYPE GROWTH RATES

HUMAN BIOBANKING ADVANCE APPLICATION MARKET - TYPE
GLOBAL HUMAN BIOBANKING ADVANCE APPLICATION - TYPE - GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

A. BIOBANKING - GEOGRAPHICAL DISTRIBUTION IN DETAIL

BIOBANKING IN THE AMERICAS
CANADA
TO ASSESS THE SCALE AND LIMITATIONS OF INDUSTRY ACCESS TO PUBLICLY-FINANCED BIOBANKS IN CANADA
THE CANADIAN LONGITUDINAL STUDY ON AGING: BIOREPOSITORY FUNCTIONS AND NETWORKS

BRAZIL
OUTCOMES TO GIVE TO CONTRIBUTORS: A DEBATE IN BRAZIL

USA
STATUS ON THE DEVELOPMENT AND GROWTH OF A COMBINED SYSTEM OF REPOSITORIES AT THE UNIVERSITY OF IOWA

BIOBANKING IN EUROPE
CONSOLIDATION ON PRESENT ADVANTAGES
EUROPEAN BIOBANKS ARE CRUCIAL RESOURCES ASSETS FOR THE DISTRIBUTION OF INDIVIDUALIZED MEDICINE
COHORTS AS A POTENTIAL INSTRUMENT TO KNOW PERSONALIZED DISTINCTION
ETHICAL, LEGAL AND SOCIAL ISSUES (ELSI)
PRIORITY ISSUES FOR PERSONALIZED MEDICINE WITHIN EUROPE
BIOBANKING AND BIOMOLECULAR RESOURCES INVESTIGATE COMMUNICATIONS - EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM
FUTURE ENTRY IN TO BIGGER EUROPEAN COHORTS VIA TRANSNATIONAL BIOBANKING INFRASTRUCTURE BBMRI-LPC
9 YEARS RELATING SWISS BIOBANKS – EN ROUTE TO A SWISS BIOBANKING POLICY

GERMANY
CONSTANT AND MAINTAINANCE AND SUPPORT OF BIOBANK-BASED MEDICAL RESEARCH: A DECADE OF EXPERIENCE IN GERMANY

AUSTRIA

UNITED KINGDOM
COMBINED EFFECTIVE NETWORK OF BIOBANKS

ITALY
BIOBANKS AND ETHICAL CONCERNS IN ITALY

OTHER EUROPEAN COUNTRIES
STRATEGY DEVELOPMENT FOR EMERGING BIOBANKS ON THE EXAMPLE OF KOSOVO AND ALBANIA

BIOBANKING IN ASIA-PACIFIC
JAPAN
EVALUATION OF ID INTEGRITY WITH ABO BLOOD TYPING-QUESTIONNAIRE TO GENOMIC DATA IN JAPANESE BIOBANK
ASSESSMENT OF CELL-TYPE COMPOSITION IN PERIPHERAL BLOOD MONONUCLEAR CELLS ENHANCES VALUE OF OMICS DATA IN BIOBANK RESEARCH

SOUTH KOREA
CURRENT TRENDS IN KOREA GYNECOLOGIC CANCER BANK
EBIOBANKING SYSTEM FOR KOREA GYNECOLOGIC CANCER BANK

CHINA
ACHIEVEMENTS
BIOBANKING FOR THE BORN IN GUANGZHOU COHORT STUDY: AN INNOVATIVE RESOURCE FOR MATERNAL AND CHILD HEALTH RESEARCH IN CHINA

AIMS

ADVANTAGES
CONSTRUCTION OF SHANGHAI CANCER BIOBANK STAGE FOR RESEARCH

INDIA
OBJECTIVES
GOALS
AREAS
PRINCIPLES
THE AGE BIO-BANKING IN INDIA
TO CREATE A DISEASE-LINKED RELIABLE BIOBANK IN INDIA
MORAL CONCERNS IN BIOBANKING: STEPPING UP THE PROGRAM IN INDIA
BIOBANKING IS A PROMISING PROPOSITION IN INDIA-FACTORS
I. ETHICAL CONCERNS WITH REGARD TO BIOBANKING
PEOPLE’S PERSPECTIVE TOWARDS BIOBANKING RESEARCH
ACCEPTANCE BY CONTRIBUTORS IN BIOBANKING RESEARCH

CONSENT TYPES
REMOVAL OF CONSENT/OBLITERATION OF BIO-SAMPLES
CHIEF CAUSES FOR PULL OUT

PRIVACY AND SECRECY
II. ETHICAL ISSUES LINKED TO RESEARCH PROCEDURES

STORAGE OF SAMPLES
DERIVED OR EXTENSIVE USES OF STORED SAMPLES
RELOCATION OF SAMPLES AND INFORMATION

III. CONCLUSION
FIRST BIOBANK BY 2016 IN EASTERN INDIA

AUSTRALIA
AUSTRALIAN PROSTATE CANCER BIO-RESOURCE, 2015
ENHANCING BIO-SAMPLES QUALITY INSIDE THE BANKING SYSTEM: AN AUSTRALIAN OUTLOOK

BIOBANKING IN REST OF WORLD
THE CONSEQUENCES OF MINI-BIOBANK IN HAZARDOUS CLIMATES IN IRAQ
BIODIVERSITY/ENVIRONMENTAL MICROBIAL STOREHOUSE SYSTEM IN EMERGING NATIONS-SPOTLIGHT ON NIGERIA
THE PROGRESS OF THE NATIONAL BIOBANKING INDUSTRY FOR PRESERVATION OF SOUTH AFRICAN BIODIVERSITY
QATAR BIOBANK: PUBLIC HEALTH CONCERNS REPORTED
BIOBANKING INITIATIVE IN SAUDI ARABIA: THE CEGMR BIOBANK KNOW-HOW

B. A REVIEW ON BIO “BANKS”
RELEVANCE OF BIOBANKS IN SCIENTIFIC RESEARCH

C. MAJOR PROSPECTS FOR BIOREPOSITORIES IN THE FUTURE
THE KEY IMPACT OF BIOREPOSITORIES IN ITS APPLICATIONS

BIGGEST CHALLENGES AND OPPORTUNITIES IN BIOREPOSITORIES
BIOBANKS WILL BE CHALLENGED BY INCREASING FINANCIAL PRESSURES
BIGGEST OPPORTUNITIES
PRESENT CHALLENGES OF BIOBANKING: BIOETHICAL AND PROPERTY ISSUES
ADDED VALUE OF BIOBANKS FOR HEALTH: AN EVOLUTIONARY PERSPECTIVE

FUTURE CHALLENGES

CONCLUSIONS

D. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/ INNOVATIONS/PRODUCT LAUNCHES/ETC……
CESCA THERAPEUTICS ENTERS INTO COLLABORATIVE AGREEMENT WITH CENTER FOR IMMUNE CELL THERAPIES AT MEMORIAL SLOAN KETTERING CANCER CENTER
AGILENT TECHNOLOGIES TO ACQUIRE SEAHORSE BIOSCIENCE, INDUSTRY LEADER IN TOOLS FOR MEASURING CELL METABOLISM
INTERNATIONAL STEM CELL CORPORATION ANNOUNCES NEXT PHASE OF RESEARCH COLLABORATION WITH ROHTO PHARMACEUTICAL CO., LTD. OF JAPAN
PARTNERS GET $12.3M TO ADVANCE GENOMIC MEDICINE
NEW STUDY DEMONSTRATES ABSENCE OF EXTRACTABLE ORGANIC CONTAMINANTS IN MICRONIC’S POLYPROPYLENE SAMPLE STORAGE TUBES
VALEANT PHARMACEUTICALS TO ACQUIRE SYNERGETICS USA
SYSMEX RECEIVES IN-VITRO DIAGNOSTIC APPROVAL FOR MANUFACTURING AND SALES OF THREE PLATELET AGGREGATION AGONIST REAGENT KITS
AMAG PHARMACEUTICALS COMPLETES ACQUISITION OF CORD BLOOD REGISTRY
BIOTEK SYNERGY™ NEO2 GRANTED CISBIO HTRF® CERTIFICATION
AVITA MEDICAL ANNOUNCES NEW RESEARCH PARTNERSHIP WITH UNIVERSITY OF HUDDERSFIELD
STEMCELL TECHNOLOGIES INC. ENTERS A LICENSING AGREEMENT WITH IPS ACADEMIA JAPAN, INC. FOR INDUCED PLURIPOTENT STEM CELL RESEARCH TECHNOLOGIES
IMMATICS AND MD ANDERSON ANNOUNCE LAUNCH OF IMMATICS US, INC., TO DEVELOP MULTIPLE T-CELL AND TCR-BASED ADOPTIVE CELLULAR THERAPIES
BIO-RAD INTRODUCES THE IH-500, A FULLY AUTOMATED RANDOM ACCESS SYSTEM FOR BLOOD TYPING AND SCREENING
GROUNDBREAKING CLINICAL TRIAL TO ASSESS USE OF NEWBORN STEM CELLS IN THE TREATMENT OF PEDIATRIC STROKE
GENOTYPING BEGINS ON NIDA’S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX, BIOREALM AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
STEM CELLS - PROMISING OPTIONS FOR ALTERNATIVE MEDICAL THERAPEUTIC APPROACHES
CELGENE HANDED $1 BILLION TO SMALL BIOTECH DEVELOPER JUNO THERAPEUTICS
MEDIMMUNE PARTNERS WITH THE UNIVERSITY OF SHEFFIELD TO GENERATE INNOVATIONS IN CELL FACTORY ENGINEERING SCIENCE
CYTOX AND AFFYMETRIX FORM STRATEGIC PARTNERSHIP TO DEVELOP AND COMMERCIALIZE BLOOD-BASED GENETIC ASSAY FOR ALZHEIMER’S DISEASE RISK ASSESSMENT
GENOTYPING BEGINS ON NIDA’S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX, BIOREALM, AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
MOUNT SINAI MEDICAL CENTER SELECTS STEMSOFT CLINIC
INTEGRA LIFESCIENCES COMPLETES ACQUISITION OF TEI BIOSCIENCES AND TEI MEDICAL
BLOODCENTER LAUNCHES GENE DELETION/DUPLICATION ANALYSIS
CRYOPORT PROVIDES CRYOGENIC LOGISTICS SOLUTIONS TO HEMACARE CORPORATION
BIOMATRICA, INC. ANNOUNCES RELEASE OF DNAGARD® SALIVA HT, SALIVA DNA COLLECTION
SERACARE LIFE SCIENCES ANNOUNCES STRATEGIC PARTNERSHIP WITH VIVEBIO TO ENABLE
LAKE SHORE EXHIBITING CRYOGENIC MONITORING AND CONTROL SOLUTIONS AT CEC/ICMC
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOGLUE® IN JAPAN
DNA GENOTEK INC. RECEIVES CE-IVD MARK FOR ITS OMNIGENE®•GUT MICROBIOME COLLECTION KIT
DEBIOPHARM INTERNATIONAL SA ACQUIRES FIBROTRAP SAMPLE PROCESSING TECHNOLOGY FROM SPINOMIX
SYSMEX AND LABCORP ANNOUNCE A STRATEGIC COLLABORATION FOR BLOOD-BASED MOLECULAR TESTING SERVICES AND PRODUCTS TO SUPPORT THE DEVELOPMENT OF PRECISION MEDICINE IN ONCOLOGY
RENEURON GROUP PLC S RESEARCH COLLABORATION WITH BENITEC BIOPHARMA
STEMCELL TECHNOLOGIES LAUNCHES INNOVATIVE PRODUCTS TO SUPPORT CAR T CELL RESEARCH
ULTRA LOW BINDING TUBES FOR PROTEOMICS
CALADRIUS BIOSCIENCES, INC. FINALIZES CORPORATE NAME CHANGE FROM NEOSTEM, INC.
STEMGENT, A REPROCELL GROUP COMPANY LAUNCHES A NEW HIGH PERFORMANCE SELF-REPLICATIVE RNA REPROGRAMMING KIT
TAKARA BIO EUROPE RELEASES AN INNOVATIVE IPS CELL CULTURE MEDIUM FOR PRE-CLINICAL USE: CELLARTIS® DEF-CS™ XENO-FREE CULTURE MEDIUM GÖTEBORG, SWEDEN
OCTANE AND LONZA ANNOUNCE EXCLUSIVE COLLABORATION TO EVALUATE GROUNDBREAKING AUTOLOGOUS CELL THERAPY TECHNOLOGY
AXT TO DISTRIBUTE OPENSPECIMEN BIOBANKING SOFTWARE SOLUTION
NIKON AND LONZA FORM COLLABORATION FOR CELL AND GENE THERAPY MANUFACTURING IN JAPAN
DNA GENOTEK INC. LAUNCHES MICROBIAL DNA SELF-COLLECTION KIT-OMNIGENE®•GUT PRODUCT OPTIMIZES SAMPLES FOR MICROBIOME ANALYSIS
BIOCISION AND BROOKS AUTOMATION ANNOUNCE INDUSTRY'S FIRST PORTABLE CRYOGENIC BIOSPECIMEN TRANSPORT SYSTEM WITH INTEGRATED REAL-TIME TEMPERATURE MONITORING
CRYO-CELL’S NEW CORD BLOOD PROCESSING METHOD ENABLES PARENTS TO OBTAIN BETTER CORD BLOOD UNITS FOR THEIR BABIES
AVITA MEDICAL ANNOUNCES ISSUANCE OF A NEW U.S. PATENT FOR RECELL®
TITIAN SOFTWARE EXPANDS OFFERING WITH NEW MOSAIC FREEZER MANAGEMENT
ALLIQUA BIOMEDICAL ANNOUNCES EXPANSION TO ITS EXCLUSIVE LICENSING AGREEMENT WITH CELGENE CELLULAR THERAPEUTICS
SECURE AUTOMATED CRYOGENIC STORAGE
LONZA, THE WORLD’S LEADING DEVELOPER AND MANUFACTURER OF CELLS FOR REGENERATIVE MEDICINE THERAPEUTICS, AND NIKON CORPORATION ANNOUNCED TODAY AN EXCLUSIVE COLLABORATION IN THE FIELD OF CELL AND GENE THERAPY MANUFACTURING IN JAPAN.
NEOSTEM ANNOUNCES EXPANDED CELL THERAPY MANUFACTURING RELATIONSHIP WITH KITE PHARMA
COMBIMATRIX LAUNCHES BUCCAL SWAB DNA COLLECTION AS ALTERNATIVE TO BLOOD DRAWS FOR POSTNATAL GENETIC TESTING
NEW ULTRA-LOW TEMPERATURE FREEZER OFFERS OUTSTANDING SUSTAINABILITY AND SAMPLE PROTECTION
NEOSTEM, INC AND ALLCELLS, LLC TO COLLABORATE WITH MOUNT SINAI AS PART OF $8.8 MILLION GRANT TO FURTHER STEM CELL RESEARCH
SYSMEX INOSTICS ANNOUNCES AGREEMENT WITH INDIVUTEST TO OFFER BLOOD BASED MUTATION TESTING
CELGENE TO ACQUIRE QUANTICEL PHARMACEUTICALS
CORD BLOOD REGISTRY® USES BIOLIFE SOLUTIONS CRYOSTOR® CLINICAL GRADE FREEZE MEDIA IN THE STORAGE OF UMBILICAL CORD TISSUE STEM CELLS
FLORIDA HOSPITAL CANCER INSTITUTE SELECTS STEMSOFT CLINIC
GENMAB ACHIEVES USD 10 MILLION MILESTONES IN DARATUMUMAB COLLABORATION WITH JANSSEN
ALVETEX® 3D CELL CULTURE PLATFORM REACHES NEW HEIGHTS WITH PROJECT ABOARD THE INTERNATIONAL SPACE STATION (ISS).
LONZA INTRODUCES CYTOSMART™ SYSTEM FOR WALK-AWAY LIVE CELL IMAGING
BROOKS AUTOMATION INTRODUCES BIOSTORE III CRYO AUTOMATED CRYOGENIC SAMPLE MANAGEMENT SYSTEM
BIOCISION AND BROOKS JOINT DEVELOPMENT PARTNERSHIP TO UNVEIL NEW CRYOGENIC SAMPLE HANDLING AND TRANSPORT PRODUCT
PAML AND BLOODWORKS NW SIGN LETTER OF INTENT TO COLLABORATE ON INNOVATION
BROOKS AUTOMATION INTRODUCES BIOSTORE III CRYO AUTOMATED CRYOGENIC SAMPLE MANAGEMENT SYSTEM
BIOTIME’S CLINICAL GRADE STEM CELLS FROM SUBSIDIARY ES CELL INTERNATIONAL TO BE USED IN PLANNED CIRM-FUNDED PRECLINICAL STUDIES OF HUNTINGTON’S DISEASE
BIOTIME LICENSES BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE TO MANUFACTURE CLINICAL GRADE STEM CELLS
BLOOD CENTER AFFILIATION UNVEILS NEW NAME, EXPANDED OFFERINGS TO HEALTHCARE SYSTEMS
LONZA INTRODUCES CYTOSMART™ SYSTEM FOR WALK-AWAY LIVE CELL IMAGING
FUJIFILM HOLDINGS TO ACQUIRE CELLULAR DYNAMICS INTERNATIONAL, INC.
GENVEC AND THERABIOLOGICS FORM COLLABORATION TO DEVELOP NEURAL STEM CELL MEDIATED CANCER THERAPIES
CRYO-CELL INTERNATIONAL, INC., CORD BLOOD BANKING LEADER, TAKES SIGNIFICANT OWNERSHIP STAKE IN CORD BLOOD AMERICA, INC., AND ENCOURAGES CBAI SHAREHOLDERS TO VOTE AGAINST UPCOMING SHARE AUTHORIZATION PROPOSAL
COMBIMATRIX SELECTS CRYOPORT AS LOGISTICS PARTNER FOR THE DISTRIBUTION OF ITS NEW GENETIC SCREENING SERVICE
BLUECHIIP TRACKING SOLUTIONS EXECUTING STRATEGIC PRIORITIES IN BIOBANKING
CORDLIFE PARTNERS WITH LEADING NEUROLOGIST ON STUDY IN CHILD AUTISM USING OWN CORD BLOOD STEM CELLS
LEICA EM CRYO CLEM FEATURES THE WORLD’S FIRST CRYO CLEM OBJECTIVE
PARTNERSHIP WITH LIVE CELL IMAGING COMPANY
ASTRAZENECA TO COLLABORATE WITH THE HARVARD STEM CELL INSTITUTE IN DIABETES
HANDHELD WIRELESS 1D / 2D CODE READER
BIOLIFE SOLUTIONS CRYOSTOR® CELL FREEZE MEDIA USED IN MAYO CLINIC SAFETY AND FEASIBILITY STUDY OF UMBILICAL CORD BLOOD-DERIVED CELLS FOR PEDIATRIC CARDIAC REGENERATION
EXPIRATION OF THE OPTION OF TEVA UNDER THE LICENSE AGREEMENT WITH CELLCURE NEUROSCIENCES
UNIVERSITY OF ILLINOIS AT CHICAGO SELECTS STEMSOFT CLINIC
ESPERITE PIONEERS FIRST TREATMENT WORLDWIDE OF CEREBRAL PALSY USING TWO TYPES OF STEM CELLS
GREINER BIO-ONE PRESENTS INNOVATIVE CRYO’S BIOBANKING TUBES
ESI BIO – A DIVISION OF BIOTIME, INC., ANNOUNCES ALLIANCE AGREEMENT WITH PIVOTAL SCIENTIFIC LTD FOR DISTRIBUTION OF STEM CELL PRODUCTS
PUGET SOUND BLOOD CENTER IS NOW BLOODWORKS NORTHWEST
LABCORP COMPLETES ACQUISITION OF COVANCE
BIOLIFE SOLUTIONS LAUNCHES NEW CELL THAWING MEDIA PRODUCTS IN RESPONSE TO WORLDWIDE SHORTAGE OF DEXTRAN SOLUTIONS
TIGENIX AND LONZA SIGN AGREEMENT FOR THE MANUFACTURE OF STEM CELL-BASED TREATMENT OF COMPLEX PERIANAL FISTULAS IN CROHN’S DISEASE
EPISTEM ANNOUNCES THE SUCCESSFUL EVALUATION OF NEW RNA-AMP™ (RNA-AMPLIFICATION) TECHNOLOGY
STEMGENT, A REPROCELL GROUP COMPANY AND TRANSPOSAGEN BIOPHARMACEUTICALS ENTER INTO A SERVICE PARTNERSHIP AGREEMENT PROVIDING GENETICALLY ENGINEERED STEM CELLS
TIGENIX AND LONZA SIGN AGREEMENT FOR THE MANUFACTURE OF STEM CELL-BASED TREATMENT OF COMPLEX PERIANAL FISTULAS IN CROHN’S DISEASE
INTERNATIONAL STEM CELL CORPORATION ANNOUNCES COMPLETION OF CELL BANK FOR PARKINSON'S DISEASE CLINICAL TRIAL
CELLULAR DYNAMICS MANUFACTURES CGMP HLA “SUPERDONOR” STEM CELL LINES TO ENABLE CELL THERAPY WITH GENETIC MATCHING
VITRO BIOPHARMA ANNOUNCES ADVANCES IN CLINICAL APPLICATION OF STEM CELL THERAPY FOR NEUROLOGICAL CONDITIONS
NEW HEALTHY AGEING BIOBANK MILESTONE
ALLIQUA BIOMEDICAL, INC. TO ACQUIRE CELLERATION, INC.
AGILENT TECHNOLOGIES INTRODUCES ONESEQ TO STREAMLINE CYTOGENETIC RESEARCH
CANCERCARE MANITOBA SELECTS STEMSOFT LAB
ALLIQUA BIOMEDICAL ANNOUNCES GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
VALEANT AND ASTRAZENECA TO PARTNER ON BRODALUMAB
HARVARD BIOSCIENCE ACQUIRES ALL OPERATIONS OF HEKA ELECTRONIK
BROOKS AUTOMATION ANNOUNCES COLLABORATION AGREEMENT WITH CHART INDUSTRIES
AVITA MEDICAL ANNOUNCES FIRST PATIENT ENROLLMENT IN US PIVOTAL STUDY OF RECELL® FOR THE TREATMENT OF BURNS
NEOSTEM RECEIVES DRUG MANUFACTURE LICENSE FOR IRVINE FACILITY
NEOSTEM AND INVETECH ANNOUNCE AGREEMENT TO DEVELOP CLOSED PROCESSING SYSTEM FOR CELL THERAPY MANUFACTURING
CORD BLOOD REGISTRY AND CELLULAR DYNAMICS INTERNATIONAL ANNOUNCE COLLABORATION TO REPROGRAM NEWBORN STEM CELLS INTO INDUCED PLURIPOTENT STEM CELLS
CORD BLOOD REGISTRY AND CHINA CORD BLOOD CORPORATION ENTER INTO STRATEGIC COLLABORATION
CHINA CORD BLOOD CORPORATION AND CORD BLOOD REGISTRY ENTER INTO STRATEGIC COLLABORATION
ESSENTIAL PHARMACEUTICALS PROVIDES SOLUTIONS TO KEEP CELLS AND ORGANS HEALTHY
APOLLO HEALTH AND LIFESTYLE LTD. EXPANDS ITS FOOTPRINT WITH THE ACQUISITION OF NOVA SPECIALTY HOSPITALS
BROOKS AUTOMATION ANNOUNCES COLLABORATION AGREEMENT WITH CHART
SELEXIS GENERATED RESEARCH CELL BANKS NOW FULLY SEQUENCED USING NEXT-GENERATION SEQUENCING
SYMPHOGEN A/S LICENSES THE SELEXIS SURETECHNOLOGY EXPRESSION PLATFORM AND CELL LINE
NYSCF AND THE CMTA ENTER COLLABORATION TO ADVANCE NEUROPATHIES RESEARCH
LEICA BIOSYSTEMS AND MAYO CLINIC COLLABORATE ON FUTURE OF CYTOGENETICS IMAGING
BIOTIME SUBSIDIARY ES CELL INTERNATIONAL AND GE HEALTHCARE CROSS-LICENSE PATENTS IN THE FIELD OF CELL ASSAYS FOR DRUG TESTING
TAKARA BIO INC. WILL TAKE OVER THE SUPPLY OF SC PROVEN PRODUCTS FORMERLY SUPPLIED BY STEM CELLS SCIENCES
MR SOLUTIONS ANNOUNCES THE FIRST INSTALLATIONS OF ITS SECOND GENERATION CRYOGEN FREE MAGNET TECHNOLOGY FOR INCREASED SCIENTIFIC CAPABILITIES IN PRECLINICAL MRI
GERON ANNOUNCES EARLY HSR CLEARANCE FOR GLOBAL STRATEGIC COLLABORATION WITH JANSSEN
CRYOFAB INC. (NJ) ACQUISITION OF LEADING CRYOGENIC VALVES SUPPLIERS CRYOCOMP INC. (CA)
NOVADAQ APPOINTED EXCLUSIVE WORLDWIDE DISTRIBUTOR OF LIFENET HEALTH’S DERMACELL TISSUE PRODUCTS
TOSHIBA CORPORATION SELECTS AFFYMETRIX AXIOM PLATFORM FOR ITS NEWLY LAUNCHED GENOTYPING SERVICE IN JAPAN
BLOODCENTER TO FORM STRATEGIC ALLIANCE WITH INDIANA BLOOD CENTER
CYTOMEDIX ANNOUNCES CORPORATE NAME CHANGE TO NUO THERAPEUTICS, INC.
IRVINE SCIENTIFIC INTRODUCES DMSO-FREE, CHEMICALLY-DEFINED CRYOPRESERVATION SOLUTION FOR MESENCHYMAL STEM CELLS
BLUECHIIP SIGNS INTERNATIONAL AGREEMENT FOR TECHNOLOGY INTEGRATION
SIGMA-ALDRICH COMPLETES ACQUISITION OF CELL MARQUE
CELLULAR DYNAMICS AND NORTHWESTERN UNIVERSITY TAKE FIRST STEPS TOWARD REBUILDING AN ORGAN USING MANUFACTURED HUMAN CELLS
BAKER RUSKINN BRAND PROMISES NEW TOOLS FOR CELL SCIENCE
LIFECELL CORPORATION AND NOVADAQ TECHNOLOGIES AGREE TO EARLY TRANSITION OF SPY ELITE® INTRAOPERATIVEPERFUSION ASSESSMENT SYSTEM BUSINESS BACK TO NOVADAQ.
AFFYMETRIX EXCLUSIVELY LICENSES TECHNOLOGY FROM PEPTIDE GROOVE LLP FOR HLA TYPING FROM GENOTYPING DATA
ALLIQUA BIOMEDICAL ANNOUNCES EXPANSION TO ITS EXCLUSIVE LICENSING AGREEMENT WITH CELGENE CELLULAR THERAPEUTICS
NEW BLAST FREEZERS OFFER RAPID FREEZING FOR SHORT AND LONG TERM COLD STORAGE
NEW INNOVATIONS ADVANCE UPSTREAM AND DOWNSTREAM BIOPROCESSING FOR BIOPHARMACEUTICAL MANUFACTURERS
OSIRIS AND ARTHREX ANNOUNCE AN EXCLUSIVE PARTNERSHIP FOR THE COMMERCIALIZATION AND DEVELOPMENT OF CARTIFORM®
BAKER INTRODUCES CULTIVO™ CO2 INCUBATOR
BAKER RUSKINN BRAND PROMISES NEW TOOLS FOR CELL SCIENCE
BROOKS AUTOMATION ACQUIRES FLUIDX, A LEADING PROVIDER OF CONSUMABLES AND INSTRUMENTS USED FOR BIOLOGICAL SAMPLE STORAGE
ROSLIN CELLS WORKING WITH TOKYO ELECTRON ON DEVELOPING NEW SMART CELL PROCESSING TECHNOLOGIES
CESCA THERAPEUTICS ANNOUNCES AGREEMENT WITH NEW YORK UPSTATE CORD BLOOD BANK
ROOSTERBIO SELECTS BIOLIFE SOLUTIONS CRYOSTOR® TO COMMERCIALIZE HUMAN BONE MARROW-DERIVED STEM CELLS
REPROCELL ACQUIRES THE IPS CELL BUSINESS UNIT OF STEMGENT, INC.
BRAINSTORM GRANTED EUROPEAN PATENT COVERING ITS STEM CELLS FOR THE TREATMENT OF CNS DISEASES
BIOLIFE SOLUTIONS FORMS BIOLOGISTEX CCMSM JOINT VENTURE WITH SAVSU® TECHNOLOGIES TO MARKET INTELLIGENT, CONTROLLED TEMPERATURE CONTAINERS FOR BIOLOGICS
FAILURE TO INVEST IN BIOBANK ‘MAY JEOPARDISE STORAGE OF VITAL TISSUE SAMPLES
LABCORP ANNOUNCES AGREEMENT TO ACQUIRE LIPOSCIENCE
IRVINE SCIENTIFIC INTRODUCES SERUM-FREE DIFFERENTIATION MEDIA TO ITS CELL THERAPY PRODUCT LINE
CRYOMAGNETICS ACQUIRES R & D TECTONICS
STEM CELL COMPANY REPROCELL (JAPAN) ACQUIRES 3D CELL CULTURE COMPANY REINNERVATE LTD (UK) AND HUMAN TISSUE SUPPLIER BIOSERVE (USA)
FDA CLEARS MAYO CLINIC FOR MANUFACTURE OF NUROWN AND PARTICIPATION IN BRAINSTORM’S PHASE 2 ALS TRIAL
VISTAGEN RECEIVES NOTICE OF ALLOWANCE FOR CANADIAN PATENT FURTHER EXPANDING STEM CELL TECHNOLOGY PLATFORM
BECKMAN COULTER DIAGNOSTICS AND COPAN ANNOUNCE EXPANSION OF DISTRIBUTION AGREEMENT FOR AUTOMATED SAMPLE PROCESSING SYSTEMS AND DIGITAL MICROBIOLOGY
BIOVISION INTRODUCES INDUSTRY'S MOST SIMPLIFIED CETP AND PLTP ACTIVITY ASSAY KITS
NEW HIGHLY SENSITIVE TEST TO SCREEN DONORS OF BLOOD, TISSUES, AND ORGANS FOR HEPATITIS E VIRUS RECEIVES CE MARK
ESSENTIAL PHARMACEUTICALS ANNOUNCES THE RELEASE OF CELL-ESS® SERUM REPLACEMENT FOR CELL CULTURE
CELLULAR DYNAMICS AWARDED PATENTS COVERING DERIVATION OF PLURIPOTENT STEM CELLS FROM FRESH OR BANKED HUMAN BLOOD SAMPLES
CHINA CORD BLOOD CORPORATION AND CORDLIFE GROUP LIMITEDANNOUNCE COLLABORATION TO AID ASIA-BASED PATIENTSWITH CORD BLOOD STEM CELL THERAPY
THE TECAN GROUP (SIX SWISS EXCHANGE: TECN) TODAY ANNOUNCED THE ACQUISITION OF IBL INTERNATIONAL
INTERNATIONAL STEM CELL CORPORATION SIGNS AGREEMENT INCLUDING CERTAIN TERMS FOR A DEFINITIVE LICENSE AGREEMENT WITH ROHTO PHARMACEUTICAL CO., LTD. OF JAPAN
COMBIMATRIX SIGNS CONTRACT WITH STRATOSE
CORDLIFE GROUP LIMITED AND CHINA CORD BLOOD CORPORATION ANNOUNCE COLLABORATION TO AID ASIA-BASED PATIENTS WITH CORD BLOOD STEM CELL THERAPY
LANE BLOOD CENTER AND PSBC CONFIRM AFFILIATION
PRECIOUS CELLS BIOBANK ACQUIRES STEM CELL TECHNOLOGY LEADER PHARMACELLS GROUP
BIOLIFE SOLUTIONS ANNOUNCES MANUFACTURING AGREEMENT WITH SOMAHLUTION LLC
GEISINGER AND INDIVUMED PARTNER FOR PERSONALIZED MEDICINE INITIATIVE IN THE USA
RUTGERS’ HUMAN GENETICS INSTITUTE LAB EXPANDS INTO CLINICAL TESTING
CORD BLOOD AMERICA, INC. ANNOUNCES MESENCHYMAL STEM CELL EXPANDED TISSUE SERVICE OFFERING POSITIONS COMPANY TO PARTICIPATE IN ONE OF THE FASTEST GROWING AREAS OF STEM CELL RESEARCH
TECAN UNVEILS NEW FLUENT™ LABORATORY AUTOMATION SOLUTIONS
ATCC TEAMS WITH CDC AND THERMO FISHER SCIENTIFIC ON PUBLIC HEALTH RT-PCR ASSAY
BEAUMONT, BOTSFORD, OAKWOOD REACH DEFINITIVE AGREEMENT TO CREATE NEW, NOT-FOR-PROFIT HEALTH ORGANIZATION
PARTNER WITH FLOW CYTOMETERS ANALYZERS COMPANY
CELL THERAPEUTICS, INC. ANNOUNCES CHANGE OF NAME TO CTI BIOPHARMA CORP. SEATTLE
CRYOXTRACT ANNOUNCES INTEGRATION OF CXT750 SYSTEM INTO FRANCE'S NATIONAL INSTITUTE FOR AGRICULTURAL RESEARCH FOR USE IN IMPORTANT HUMAN GUT MICROBIOME RESEARCH
CRYOXTRACT ENTERS INTO DISTRIBUTION AGREEMENTS WITH CAMBRIDGE BIOSCIENCE LTD. AND LBD LIFE SCIENCES LTD.
ALLIQUA ACQUIRES CHOICE THERAPEUTICS
CELLCENTRIC RECEIVES PATENT GRANTS FOR GENE DEMETHYLATION TECHNOLOGY
PARTNER WITH TIME-LAPSE CYTOMETERS COMPANY
CELLULAR DYNAMICS ANNOUNCES LAUNCH OF ICELL(R) DOPANEURONS, NEURAL FLOOR PLATE-DERIVED MIDBRAIN DOPAMINERGIC NEURONS
BROOKS AUTOMATION, THE UNIVERSITY OF OXFORD AND UK BIOCENTRE ANNOUNCE PURCHASE OF MULTIPLE BROOKS AUTOMATED SAMPLE MANAGEMENT SYSTEMS
ROSLIN CELLS TO MANUFACTURE BLOOD CULTURED FROM STEM CELLS
NEOSTEM ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE CALIFORNIA STEM CELL, INC.
ATCC EXPANDS ITS PORTFOLIO OF CERTIFIED REFERENCE MATERIALS TO INCLUDE QUANTITATIVE MYCOPLASMA DNA
ALLIQUA BIOMEDICAL, INC. TO ACQUIRE CELLERATION, INC.
LONZA AND BIOWA SIGN POTELLIGENT® CHOK1SV CELL LINE TECHNOLOGY LICENSING AGREEMENT WITH ARGEN-X
COMBIMATRIX ANNOUNCES PARTNERSHIP WITH AMERICAN PATHOLOGY PARTNERS TO PROVIDE PRODUCTS OF CONCEPTION TESTING
TAKARA BIO OBTAINS A GOVERNMENTAL GRANT FOR COMMERCIALIZATION OF ITS TCR GENE THERAPY PROJECTS
BRAINSTORM GRANTED KEY US PATENT FOR ITS AUTOLOGOUS STEM CELL TECHNOLOGY
LONZA AND BIOWA SIGN POTELLIGENT® CHOK1SV CELL LINE TECHNOLOGY LICENSING AGREEMENT WITH ARGEN-X
MODULAR VERTICAL FREEZER RACK FOR BIOBANKING LAUNCHED BY MICRONIC
GREINER BIO-ONE PRESENTS INNOVATIVE CRYO.S BIOBANKING TUBES
THERMO FISHER SCIENTIFIC COMPLETES ACQUISITION OF LIFE TECHNOLOGIES CORPORATION
BIOPTA ANNOUNCES LAUNCH OF INDUSTRY’S FIRST CATALOGUE OF IN VITRO HUMAN TISSUE ASSAYS
THERMO FISHER SCIENTIFIC REACHES AGREEMENT TO SELL ITS CELL CULTURE, GENE MODULATION AND MAGNETIC BEADS BUSINESSES TO GE HEALTHCARE
BIOMATRICA AND SIGMA-ALDRICH SIGN DISTRIBUTION AGREEMENT
ATHERSYS ANNOUNCES NEW PATENTS IN JAPAN FOR STEM CELL AND REGENERATIVE MEDICINE TECHNOLOGY
CELL THERAPY'S HEART TISSUE REGENERATION HOPE
CELLULAR DYNAMICS SIGNS AGREEMENT WITH NESTLE INSTITUTE OF HEALTH SCIENCES TO SUPPLY ICELL® AND MYCELL® PRODUCTS FOR NUTRITIONAL RESEARCH
LIFECELL CORPORATION ACQUIRES ADVANCED ADIPOSE TISSUE INJECTOR
COMBIMATRIX ANNOUNCES CONTRACT WITH GALAXY HEALTH NETWORK
COMBIMATRIX ANNOUNCES PARTNERSHIP WITH PROPATH TO PROVIDE PRODUCTS OF CONCEPTION TESTING
STEMSOFT SOFTWARE INC. AND JAF CONSULTING, INC. ANNOUNCE COLLABORATIVE PARTNERSHIP
THERMO FISHER SCIENTIFIC REACHES AGREEMENT TO SELL ITS CELL CULTURE, GENE MODULATION AND MAGNETIC BEADS BUSINESSES TO GE HEALTHCARE
NEW DMSO-RESISTANT 1536 WELL STORAGE PLATE
BMG LABTECH AND INVIVOSCIENCES, INC. INITIATE MARKET COLLABORATION TO ACCELERATE DRUG DISCOVERY IN ENGINEERED 3D TISSUES
LOW PROFILE SCREW CAPS DESIGNED IN CONJUNCTION WITH THE HANNOVER UNIFIED BIOBANK LAUNCHED BY MICRONIC
QUEENSLAND NODE OF APCB GAIN ACCESS TO UNIQUE SAMPLES
THERMO FISHER SCIENTIFIC BRINGS SEVERAL INNOVATIONS IN BIOPROCESSING TECHNOLOGIES AND SYSTEMS

E. MARKET TRENDS
GROUNDBREAKING TECHNOLOGY COLLABORATION TO OPTIMIZE MEDICAL RESEARCH
FIRST 300 CELL LINES TO SUPPORT AUTISM, HEART, LIVER, LUNG AND EYE DISEASE RESEARCH
TOWARDS ‘ENGAGEMENT 2.0’: INSIGHTS FROM A STUDY OF DYNAMIC CONSENT WITH BIOBANK PARTICIPANTS
FINDING BIOMARKERS FOR EARLY LUNG CANCER DIAGNOSIS
BIOBANKING VIABLE IMMUNE CELLS - TRANSPORTATION MATTERS!
CANCER BIOBANK INFORMS FUTURE TREATMENT
WORLD’S FIRST T CELL-QUALIFIED SERUM REPLACEMENT NOW AVAILABLE
BIOBANKING: A VITAL ASSET FOR BELGIUM SCIENTIFIC EXCELLENCE
PLASMA BIOBANKING: MAXIMIZING PATIENT SAMPLES
BRIDGING ‘BIOBANKING’ AND BIOMEDICAL RESEARCH ACROSS EUROPE AND AFRICA: ‘B3AFRICA’ LAUNCHED IN CAPE TOWN
FINDING THE BEST WAY TO PROCESS GUT MICROBIOME SAMPLES
INNOVATION IN BIOBANKING: PUSHING THE BOUNDARIES
NEW RESEARCH TOOL TRACKS REAL-TIME DNA-PROTEIN BINDING IN CELLS
SEOULIN BIOSCIENCE TO DISTRIBUTE CELLULAR DYNAMICS’ PRODUCTS IN KOREA
CRYOGENIC STORAGE SOLUTION AVAILABLE IN EUROPE
A NEXT-GEN BIOBANK THAT’S BASED ON THE CLOUD
HEALTH RESEARCH GROUP MAKES RECOMMENDATIONS ON EU DATA PROTECTION REFORMS
GENOTYPING BEGINS ON NIDA’S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX, BIOREALM, AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
REG-GALAPAGOS LICENSES ORGANOID TECHNOLOGY FROM THE HUB FOUNDATION FOR USE IN CYSTIC FIBROSIS AND IBD RESEARCH
CCFA LAUNCHES DEVELOPMENT OF WORLD’S LARGEST RESEARCH DATABASE FOR CROHN’S DISEASE AND ULCERATIVE COLITIS
THE JOINT VENTURE OF SYNOVIAL TISSUE CRYOPRESERVATION
ANTIFREEZE POLYMER PROTECTS CELLS AS THEY THAW
AUSTRALIA’S FIRST COMPREHENSIVE SKIN CANCER TISSUE BANK
AWARENESS OF THE PROCURE BIOBANK
BIOSAMPLES AND CRYOPRESERVATION: WHAT TUBE SHOULD I USE?
IBBL TEACHES THE INS AND OUTS OF BIOBANKING
NHLBI NEXT GEN CONSORTIUM PARTNERS WITH WICELL TO DISTRIBUTE OVER 1,500 WELL-CHARACTERIZED, NOVEL CELL LINES FOR USE IN DISEASE RESEARCH
AUTOMATED PBMC ISOLATION FOR BIOBANKING WITH TECAN’S FREEDOM EVO®
BIOTEK EXPANDS IN THE UNITED KINGDOM
ECACC AND DS PHARMA – 10 YEARS SUPPORTING CELL CULTURE SCIENCE IN JAPAN
DRIED BLOOD SPOTS: NEW APPLICATIONS FOR BIOBANKING?
MULTICARE, BLOODWORKS NW EXPAND SOUTH SOUND CORD BLOOD COLLECTION
NEW ULTRA-LOW TEMPERATURE FREEZER OFFERS OUTSTANDING SUSTAINABILITY AND SAMPLE PROTECTION
BIOBANKING FOR GLOBAL PROSTATE CANCER RESEARCH COLLABORATION
THE UK HAS JOINED THE BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE - EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM (BBMR-ERIC) AT ITS GENERAL ASSEMBLY
BIOBANKING COLLABORATION FOR LUNG CANCER RESEARCH
LONG-TERM BIOBANKING: HOW LONG CAN YOU HOLD SAMPLES?
CONTROLLING SAMPLE EXPOSURE TO TEMPERATURE VARIABILITY
THL OBTAINED PERMISSION TO TRANSFER OLD SAMPLE COLLECTIONS TO THL BIOBANK
CHOOSING COLLECTION KITS VERSUS BULK SUPPLIES
FUTURE OF BIOBANKING AND TRANSLATIONAL RESEARCH IN CHINA
UW TO SELL PATIENT TISSUE SAMPLES TO SUPPORT RESEARCH
MSC FROM CORD TISSUE USED TO TREAT GRAFT-VERSUS-HOST DISEASE
FIRST PATIENT SUCCESSFULLY TRANSPLANTED WITH CRYOPRESERVED (FROZEN) NICORD® IN GAMIDA CELL’S ONGOING PHASE I/II CLINICAL TRIAL FOR BLOOD CANCERS
STORE FOR 20 MILLION BIO-SAMPLES OPENS IN MILTON KEYNES
PASS THE TISSUE: UA CREATES BIO REPOSITORY TO SHARE WITH COMPETING UNIVERSITIES
COLD STORAGE: DEEP-FREEZE UNIT IS VITAL TO OKLAHOMA MEDICAL RESEARCH FOUNDATION'S WORK
NEW EUROPEAN STORAGE BANK FOR STEM CELL STUDIES COMING TO BABRAHAM RESEARCH CAMPUS
STEM CELLS: FIRST THERAPY APPROVED BY EU
NATIONAL BIOBANK SYMPOSIUM STRENGTHENS COOPERATION IN THE BIOBANK RESEARCH
FROM DRIED COD TO TISSUE SAMPLE PRESERVATION
HEMATOLOGIC CANCERS: UMBILICAL CORD TRANSPLANTATION
NEW METHOD TO MULTIPLY STEM CELLS MAKES CORD BLOOD EVEN MORE VALUABLE
BIOHEART ANNOUNCES PARTNERSHIP IN COLOMBIA
SURVEY OF BIOBANKS 2014 IN AUSTRALIA
BIOBANKS COOPERATION WILL BRING OPPORTUNITIES TO THE INDIVIDUAL TREATMENT OF PATIENTS PUBLISHED
LUXEMBOURG’S BIOBANK COLLABORATES WITH US NATIONAL CANCER INSTITUTE
IBBL IS CENTRAL BIOBANK FOR A NEW EUROPEAN CANCER RESEARCH PROGRAMME
CORD BLOOD CURE FOR AUTISM
RESEARCH THAT EXPLORES THE USE OF UMBILICAL CORD BLOOD CELLS
NEW DISTRIBUTION PARTNER FOR BIOTISSUE IN GERMANY, AUSTRIA AND SWITZERLAND
RESEARCH THAT EXPLORES THE USE OF UMBILICAL CORD BLOOD CELLS
TWO NEW CHORDOMA CELL LINES DEVELOPED, HEADING TO REPOSITORY
VALLEY MEDICAL CENTER AND PSBC PARTNER IN CORD BLOOD PROGRAM
COULD PREMATURE BABIES BENEFIT FROM THEIR OWN CORD BLOOD STEM CELLS
NCI BIOBANK SURVEY
THL BIOBANK IN FINLAND RECEIVES LICENSE TO OPERATE
FAMILYCORD INTRODUCES FAMILYCORD VENEZUELA
PLASTICELL SIGNS DEAL WITH JCR PHARMACEUTICALS TO USE COMBICULT ® STEM CELL TECHNOLOGY IN JAPAN
EBISC – THE FIRST EUROPEAN BANK FOR INDUCED PLURIPOTENT STEM CELLS
SUCCESSFUL RELEASE OF SAMPLE TO TREAT SCID
WICELL EXPANDS OFFERINGS FOR RESEARCHING HUMAN DISEASE WITH CELL LINES DESIGNED BY LIFE TECHNOLOGIES FOR FLUORESCENT PROTEIN EXPRESSION
BIOBANKING FROM THE PATIENT PERSPECTIVE
THE FUTURE OF BIOBANKING
THE CHALLENGE: RECRUIT 500,000 PARTICIPANTS
2015 EU DATA PROTECTION REGULATION – IMPACT ON RESEARCH UPDATES
LATEST CRYO-CELL INTERNATIONAL DEVELOPMENTS
CORD BLOOD STEM CELLS CAN TREAT OVER 80 LIFE-THREATENING DISEASES
ENRICHING DATASETS THROUGH NORWEGIAN BIOBANK DATA FROM LIFANDIS AS AND THE IMS PYGARGUS METHODOLOGY

F. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX
A. RESEARCH FOCUS
B. ABOUT AXIS RESEARCH MIND
C. DISCLAIMER
D. FEEDBACK
LIST OF TABLES/CHARTS

I. REPORT FOCUS
1. COMPILATION OF STUDIES DESCRIBING THE STABILITY OF SPECIFIC BIOMARKERS FOR BIOSPECIMENS (BIOFLUIDS, CELLS, TISSUES) AS A FUNCTION OF STORAGE TEMPERATURE/DURATION
2. STORAGE TIME, NUMBER, TYPE OF SAMPLE AND AVERAGE RIN VALUES
3. DNA SAMPLES AND THEIR SOURCE
4. A LIST OF POSSIBLE PRE-ANALYTICAL VARIABLES THAT COULD AFFECT SAMPLES IN A CANCER BIOBANK

J. HUMAN BIOBANKING APPLICATIONS - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
5. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
6. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)

EUROPE
7. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
8. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF EUROPEAN MARKET VALUE - (2017-2020)

ASIA-PACIFIC
9. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
10. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
11. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
12. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF REST OF WORLD MARKET VALUE - (2017-2020)

K. HUMAN BIOBANKING ADVANCED APPLICATIONS - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
13. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
14. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)

EUROPE
15. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
16. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF EUROPEAN MARKET VALUE - (2017-2020)

ASIA-PACIFIC
17. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
18. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
19. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
20. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF REST OF WORLD MARKET VALUE - (2017-2020)

II. MARKET ANALYSIS
21. GLOBAL HUMAN BIOBANKING - SEGMENTATION BY APPLICATION

HUMAN BIOBANKING APPLICATION - GLOBAL
22. HUMAN BIOBANKING APPLICATION MARKET - CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
23. HUMAN BIOBANKING APPLICATION MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
24. HUMAN BIOBANKING APPLICATION MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

HUMAN BIOBANKING APPLICATION – BY GEOGRAPHY
NORTH AMERICA
25. HUMAN BIOBANKING APPLICATION MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
26. HUMAN BIOBANKING APPLICATION - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
27. HUMAN BIOBANKING APPLICATION MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
28. HUMAN BIOBANKING APPLICATION MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
29. HUMAN BIOBANKING APPLICATION MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
30. HUMAN BIOBANKING APPLICATION MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
31. HUMAN BIOBANKING APPLICATION MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
32. HUMAN BIOBANKING APPLICATION MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

HUMAN BIOBANKING - BY APPLICATIONS TYPE
33. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
34. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF GLOBAL MARKET VALUE - (2017-2020)

HUMAN BIOBANKING APPLICATION - TYPE - BY GEOGRAPHY
STEM CELLS
35. STEM CELLS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
36. STEM CELLS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
37. STEM CELLS MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
38. STEM CELLS MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
39. STEM CELLS MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
40. STEM CELLS MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
41. STEM CELLS MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
42. STEM CELLS MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
43. STEM CELLS MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
44. STEM CELLS MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

ADVANCED APPLICATION
45. ADVANCED APPLICATION MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
46. ADVANCED APPLICATION MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
47. ADVANCED APPLICATION MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
48. ADVANCED APPLICATION MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
49. ADVANCED APPLICATION MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
50. ADVANCED APPLICATION MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
51. ADVANCED APPLICATION MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
52. ADVANCED APPLICATION MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
53. ADVANCED APPLICATION MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
54. ADVANCED APPLICATION MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

ADVANCED APPLICATION - BY TYPE
55. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
56. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF GLOBAL MARKET VALUE - (2017-2020)

ADVANCED APPLICATION – TYPE – BY GEOGRAPHY
BIOMARKERS
57. BIOMARKERS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
58. BIOMARKERS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
59. BIOMARKERS MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
60. BIOMARKERS MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
61. BIOMARKERS MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
62. BIOMARKERS MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
63. BIOMARKERS MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
64. BIOMARKERS MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
65. BIOMARKERS MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
66. BIOMARKERS MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

DRUG DISCOVERY
67. DRUG DISCOVERY MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
68. DRUG DISCOVERY MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
69. DRUG DISCOVERY MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
70. DRUG DISCOVERY MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
71. DRUG DISCOVERY MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
72. DRUG DISCOVERY MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
73. DRUG DISCOVERY MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
74. DRUG DISCOVERY MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
75. DRUG DISCOVERY MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
76. DRUG DISCOVERY MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

GENOMICS
77. GENOMICS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
78. GENOMICS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
79. GENOMICS MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
80. GENOMICS MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
81. GENOMICS MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
82. GENOMICS MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
83. GENOMICS MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
84. GENOMICS MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
85. GENOMICS MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
86. GENOMICS MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

FORENSICS
87. FORENSICS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
88. FORENSICS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
89. FORENSICS MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
90. FORENSICS MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
91. FORENSICS MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
92. FORENSICS MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
93. FORENSICS MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
94. FORENSICS MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
95. FORENSICS MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
96. FORENSICS MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

BLOOD AND BLOOD PRODUCTS
97. BLOOD AND BLOOD PRODUCTS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
98. BLOOD AND BLOOD PRODUCTS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
99. BLOOD AND BLOOD PRODUCTS MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
100. BLOOD AND BLOOD PRODUCTS MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
101. BLOOD AND BLOOD PRODUCTS MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
102. BLOOD AND BLOOD PRODUCTS MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
103. BLOOD AND BLOOD PRODUCTS MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
104. BLOOD AND BLOOD PRODUCTS MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
105. BLOOD AND BLOOD PRODUCTS MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
106. BLOOD AND BLOOD PRODUCTS MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

ORGANS
107. ORGANS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
108. ORGANS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
109. ORGANS MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
110. ORGANS MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
111. ORGANS MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
112. ORGANS MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
113. ORGANS MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
114. ORGANS MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
115. ORGANS MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
116. ORGANS MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

RESEARCH
117. RESEARCH MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
118. RESEARCH MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
119. RESEARCH MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
120. RESEARCH MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
121. RESEARCH MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
122. RESEARCH MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
123. RESEARCH MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
124. RESEARCH MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
125. RESEARCH MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
126. RESEARCH MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

PHARMACEUTICALS
127. PHARMACEUTICALS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
128. PHARMACEUTICALS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
129. PHARMACEUTICALS MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
130. PHARMACEUTICALS MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
131. PHARMACEUTICALS MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
132. PHARMACEUTICALS MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
133. PHARMACEUTICALS MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
134. PHARMACEUTICALS MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
135. PHARMACEUTICALS MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
136. PHARMACEUTICALS MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

OTHER HUMAN BIOBANKING APPLICATION
137. OTHER HUMAN BIOBANKING APPLICATION MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2014-2020, IN USD$ MILLION)
138. OTHER HUMAN BIOBANKING APPLICATION MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2017-2020)

NORTH AMERICA
139. OTHER HUMAN BIOBANKING APPLICATION MARKET - USA, CANADA AND MEXICO - (2014-2020, IN USD$ MILLION)
140. OTHER HUMAN BIOBANKING APPLICATION MARKET - % OF USA, CANADA AND MEXICO MARKET VALUE - (2017-2020)

EUROPE
141. OTHER HUMAN BIOBANKING APPLICATION MARKET - UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE - (2014-2020, IN USD$ MILLION)
142. OTHER HUMAN BIOBANKING APPLICATION MARKET - % OF UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE MARKET VALUE - (2017-2020)

ASIA-PACIFIC
143. OTHER HUMAN BIOBANKING APPLICATION MARKET - CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2014-2020, IN USD$ MILLION)
144. OTHER HUMAN BIOBANKING APPLICATION MARKET - % OF CHINA, JAPAN, INDIA, AUSTRALIA, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2017-2020)

REST OF WORLD
145. OTHER HUMAN BIOBANKING APPLICATION MARKET - BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA - (2014-2020, IN USD$ MILLION)
146. OTHER HUMAN BIOBANKING APPLICATION MARKET - % OF BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA AND REST OF AFRICA MARKET VALUE - (2017-2020)

B. GROWTH RATE ANALYSIS
147. HUMAN BIOBANKING APPLICATION MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2014-2020)
148. HUMAN BIOBANKING APPLICATION - TYPE - % GROWTH RATE FORECASTS FOR STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - (2014-2020)
149. HUMAN BIOBANKING ADVANCE APPLICATION - TYPE - % GROWTH RATE FORECASTS FOR BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - (2014-2020)

C. INVESTMENT FOCUS
150. HUMAN BIOBANKING APPLICATION - FORECASTED CAGR% - 2014-2020 - TOP 10 COUNTRIES - USA, GERMANY, UNITED KINGDOM, BRAZIL, SPAIN, CHINA, JAPAN, SOUTH KOREA, SOUTH AFRICA AND INDIA
151. HUMAN BIOBANKING APPLICATION - TYPE - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - FORECASTED CAGR% - 2014-2020 - TOP 10 COUNTRIES - USA, GERMANY, UNITED KINGDOM, BRAZIL, SPAIN, CHINA, JAPAN, SOUTH KOREA, SOUTH AFRICA AND INDIA
152. HUMAN BIOBANKING ADVANCE APPLICATION - TYPE - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - FORECASTED CAGR% - 2014-2020 - TOP 10 COUNTRIES - USA, GERMANY, UNITED KINGDOM, BRAZIL, SPAIN, CHINA, JAPAN, SOUTH KOREA, SOUTH AFRICA AND INDIA

III. INDUSTRY OVERVIEW
153. CCB INVENTION OF METHODS FOR DATA SOURCING OF BIOLOGICAL SAMPLES TO ALL TYPES OF BIOBANKS
154. CCB INVENTION TO BIOBANKS FOR MAINTAINING MINIMUM STANDARDS
155. CCB INVENTION TO BIOBANKS FOR BEST PRACTICE STANDARDS
156. METHODS TO LINK / DELINK DATA / SAMPLES WITH THEIR IDENTIFIERS
157. WORLDWIDE KEY PLAYERS INTO HUMAN BIOBANKING INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
I. REPORT FOCUS

A. INTRODUCTION
BIOREPOSITORY
CLASSIFYING BIOBANKS
STORING SAMPLES IN A BIOBANK
BIOSPECIMEN SECURITY AND STORAGE

THE GENERATIONAL EVOLUTION OF BIOBANK

PUTTING TOGETHER A BIO BANK WITH ITS REQUIREMENTS AND CAPACITIES
TECHNICAL REQUIREMENTS
FUNCTIONAL REQUIREMENTS

BIOREPOSITORY OPERATIONS
GETTING A BIOREPOSITORY ACCREDITED
THE ROLE OF SYNTHETIC DATA IN BIOBANK ANALYSIS

B. BIOBANKING BENEFITS
CONCLUSION

C. BIOSPECIMENS (COLLECTION, PROCESSING, STORAGE, RETRIEVAL AND DISSEMINATE)
BIOSPECIMENS IN CANCER RESEARCH

BIOSPECIMENS - THE LEGACY PLAN
DECADES OLD SPECIMENS MAY BE TODAY’S RESEARCH TREASURES

BIOSPECIMEN MANAGEMENT SYSTEM
THE MODERN APPROACH TO BIOBANKING
ISOLATING STOMACH-CELL POPULATIONS USING LCM
RESULTS FROM THE BPV PROGRAM
EVALUATION OF PRE-ANALYTICAL FACTORS ON IDENTIFICATION
OF COPY NUMBER VARIATIONS
THE IMPACT OF EX-VIVO ISCHEMIA TIME ON QUALITY OF RNA
THE IDEAL PHYSICAL ENVIRONMENT FOR BIOSPECIMENS
CASE STUDY: ADVANCED IT SYSTEM FOR RESEARCH BIOREPOSITORY
PHYSICAL PHENOMENON AT LOW TEMPERATURES
BIOLOGICAL PHENOMENON AT LOW TEMPERATURES
STORAGE METHODS FOR VARIOUS BIOSPECIMENS
1. STORING PROTEINS AND PURIFIED NUCLEIC ACIDS
2. STORING CRYO-PRESERVED CELLS
3. STORING TISSUES
CONCLUSION

TRANSPORTING BIOSPECIMENS

EFFECTS OF TRANSPORTATION ON MONONUCLEAR CELLS
FINDING BIO-SAMPLES
OUT OF THE COLD-DRY STATE
BANKING ON SUCCESS FOR PRECISION MEDICINE
THE CLOSE OF THE ULTIMATE PERIOD IN BIO-BANKING
COST OF VALUE STUDY: RELATE THE THEORY TO BIOBANKS

MALFUNCTION COSTS:

EXTERNAL STOPPAGE COSTS:
BIOBANK ECONOMIC MODELING TOOL: A COST IMPROVEMENT DEVICE FOR CONTINUITY OF BIO-BANKS
INSTITUTION OF AN ISO15189 ACCREDITED BIO-BANK FOR GLOBAL CLINICAL RESEARCH STUDIES
CRITICAL MOVES TO BUILD BIO-BANKS: STAGE WISE PROCESS FOR LOW INCOME NATIONS
THE INSTITUTION OF A BIO-BANK AND COHORT NETWORK (BCNET) FOR LOW AND MIDDLE INCOME COUNTRIES
BIO-BANKING AND TRANSLATIONAL MEDICINE: THE SCHOLARLY OUTLOOK
A WORKABLE METHODOLOGY DEVISED BY BIO-BANK GRAZ: A REPRESENTATION FOR OTHER UNIVERSITY-BASED INSTITUTIONS
THE SUSTAINABILITY ISSUE OF A COMMUNITY HOSPITAL-BASED BIO-BANK AND CORE MOLECULAR LABORATORY: THE BEAUMONT UNDERSTANDING
TO MAINTAIN A DISEASE CENTERED BIO-BANKING - AN ACTIVE APPROACH

D. BIOBANKING PRINCIPLES
NORMS BASED ON INTERFACE COMPREHENSION
DATA STANDARDS ARE NOT MAXIMIZED IN RESEARCH BIO-BANKING
DATA STANDARDS - PROPOSED BY OBBR AND ISBER
DATA STANDARDS PROGRAM FOR BIO-BANKS
DESIGN OF A REGISTRY OF STANDARD OPERATING PROTOCOLS FOR TISSUE COMPILATION

E. PATH BREAKING TECHNOLOGIES
THE BIO-BANK INFORMATION MANAGEMENT SYSTEM LIFE CYCLE ORGANIZATION AND THE BIMS CLOUD MANAGEMENT PLATFORM
AMALGAMATION OF STANDARD PRE-ANALYTICAL CODE WITH BIO-BANK ORGANIZATION SOFTWARE FREEZER PRO
EVALUATION OF COMPUTERIZATION TECHNOLOGIES AND PHYSICAL STORAGE AND RECOVERY
FUTURE OUTLOOK AND CONCERNS IN THE SETUP OF SOFTWARE SOLUTIONS IN AN INTERDISCIPLINARY CLINICAL BIOBANK
A MECHANICAL LABORATORY WORKFLOW FOR STOOL DNA REMOVAL
CONSISTENT WORKFLOW FOR BIO-MATERIAL APPEALS
PARTIALLY COMPUTERIZED BIO-BANK SAMPLE PROCESSING WITH A 384 HIGH DENSITY SAMPLE TUBE ROBOT DEPLOYED IN CANCER AND CARDIOVASCULAR RESEARCH
AN AUTONOMOUS APPRAISAL OF THE CRYOXTRACT CXT350 FROZEN BIO-SPECIMEN CORING APPLICATION WITH TISSUE AND STOOL FECAL SAMPLES
HEAT STANDARDIZATION OF TISSUE SAMPLES SUPPORTS MEASUREMENT WITHOUT INTRUSION FROM POST-MORTEM OCCURRENCES AND PERMITS FOR REFINEMENT BECAUSE OF MINIMIZED INTRA GROUP VARIABILITY
BIOT CRYOCARRIER - STANDARDIZED CRYOGENIC TEMPERATURE HANDLING OF BIOSPECIMENS
PROTECTION BY VAPORIZATION FOR BIO-BANKING
OPTIMUM SPECIMEN SECURITY WITH COMPLETE AUTOMATION CHARACTERISTICS: THE AUTOMATED LN2 VAPOUR PHASE FREEZER
EXERCISE OF ELECTRONIC P-CHIPS IN A MONO AND DUOTAGGIN

Companies Mentioned


NORTH AMERICA
VERICEL CORPORATION
ACORDA THERAPEUTICS, INC.
ALPHA CORD, INC.
AFFYMETRIX, INC.
CELLERANT THERAPEUTICS, INC.
CRYO-CELL INTERNATIONAL, INC.
MESOBLAST, INC.
ATGC LABS
AUTOGEN, INC.
BARBER NICHOLS
BECKMAN COULTER, INC.
BIOCISION
U.S. STEM CELL, INC.
BIOLIFE SOLUTIONS, INC.
BIOLOGICAL SPECIMEN INVENTORY SYSTEM
BIOMATRICA, INC.
BIOSTORAGE, LLC.
CTI BIOPHARMA CORP.
CHART INDUSTRIES, INC.
CHARTER MEDICAL, LTD.
CORCELL, INC.
CORD BLOOD REGISTRY
CORE DYNAMICS (USA), INC.
CRYOLIFE, INC.
CRYOMAGNETICS, INC.
CRYOPLUS, INC.
CRYOXTRACT
CUSTOM BIOGENIC SYSTEMS
DATAWORKS DEVELOPMENT, INC.
DNA GENOTEK, INC.
EPL ARCHIEVES, INC.
GENZYME CORP.
GILEAD SCIENCES, INC.
HAMILTON STORAGE TECHNOLOGIES
LABVANTAGE SOLUTIONS, INC.
LABWARE, INC.
LIFENET HEALTH
CALADRIUS BIOSCIENCES, INC.
EPPENDORF, INC.
NOVARE BIOLOGISTICS
ORIGEN BIOMEDICAL, INC.
OSIRIS THERAPEUTICS, INC.
PACIFIC BIO-MATERIAL MANAGEMENT, INC.
PROMEDDX, LLC
PROVIA LABORATORIES, LLC
QIAGEN NV
RAND CORPORATION
RURO
SERACARE LIFE SCIENCES
SCIENTIFIC INSTRUMENTS, INC.
SP SCIENTIFIC
SPECTROCELL, INC.
ABBOTT LABORATORIES
STEELGATE, INC.
TRILLIUM THERAPEUTICS, INC.
STEM CELLS, INC.
STEMCELL TECHNOLOGIES, INC.
LIFELINE® CELL TECHNOLOGY
THERMO FISHER SCIENTIFIC, INC.
CESCA THERAPEUTICS, INC.
TRANS-HIT BIOMARKERS, INC.
VAISALA, INC.
VIACORD
VITAL THERAPIES, INC.
WHEATON SCIENCE PRODUCTS, INC.

EUROPE
PANASONIC BIOMEDICAL SALES EUROPE B.V
EPISTEM LTD.
AQIX
B & C GROUP
BBMRI
LIFEGENE
BIOBANK IRELAND TRUST
BIOKRYO GMBH
BIOREP SRL P.IVA
BIOSTORAGE TECHNOLOGIES, INC.
BOEHRINGER INGELHEIM, GMBH
CELLS4LIFE, LTD.
CRYO BIO SYSTEM
CRYO-SAVE, AG
DECODE GENETICS
GE HEALTHCARE LIFE SCIENCES
GENESISBPS
HIGHRES BIOSOLUTIONS
INDIVUMED
LIFEGENE BIOBANK
LIFELINES COHORT AND BIOBANK (LIFELINES)
LINDE GAS CRYOSERVICES B.V.
MODUL-BIO SAS
MTS CRYOSTORES UK LTD
NORAY BIOINFORMATICS S.L.U.
RENEURON GROUP PLC
SANOFI AVENTIS
SOVENTEC GMBH
STIRLING CRYOGENICS & REFRIGERATION BV
TECAN
TISSUE SOLUTIONS
UK STEM CELL BANK

ASIA-PACIFIC
COLE PARMER INSTRUMENT, CO.
CORDLIFE PTE., LTD.
CRYOCORD SDN. BHD.
CRYOLOGIC PTY. LTD.
GENESEARCH
OCIMUM BIOSOLUTIONS
RELIANCE LIFE SCIENCES
CHINA CORD BLOOD CORPORATION

REST OF WORLD
BABYCELL EGYPT
GAMIDA CELL LTD.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

Browse similar reports by category:
Biotechnology
Axis Research Mind

Our Clients